Fifth Third Bancorp Vericel Corp Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Vericel Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 1,194 shares of VCEL stock, worth $67,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,194

Previous 1,088 9.74%

Holding current value

$67,687

Previous $49,000 2.04%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$42.25 - $53.56 $4,478 - $5,677	106 Added 9.74%	1,194 $50,000
Q2 2024 Jul 22, 2024	SELL	$41.71 - $52.9 $7,799 - $9,892	-187 Reduced 14.67%	1,088 $49,000
Q1 2024 Apr 23, 2024	BUY	$32.52 - $52.33 $3,577 - $5,756	110 Added 9.44%	1,275 $66,000
Q4 2023 Jan 19, 2024	SELL	$30.85 - $37.09 $1,388 - $1,669	-45 Reduced 3.72%	1,165 $41,000
Q2 2023 Jul 25, 2023	BUY	$29.0 - $38.37 $9,715 - $12,853	335 Added 38.29%	1,210 $45,000
Q1 2023 Apr 24, 2023	SELL	$23.85 - $31.34 $1,240 - $1,629	-52 Reduced 5.61%	875 $25,000
Q4 2022 Jan 25, 2023	SELL	$17.65 - $27.37 $1,606 - $2,490	-91 Reduced 8.94%	927 $0
Q3 2022 Oct 25, 2022	SELL	$22.62 - $32.54 $1,673 - $2,407	-74 Reduced 6.78%	1,018 $24,000
Q2 2022 Aug 04, 2022	SELL	$22.88 - $39.45 $4,370 - $7,534	-191 Reduced 14.89%	1,092 $27,000
Q1 2022 Apr 19, 2022	BUY	$31.69 - $43.29 $20,535 - $28,051	648 Added 102.05%	1,283 $49,000
Q4 2021 Feb 01, 2022	BUY	$35.2 - $52.6 $5,737 - $8,573	163 Added 34.53%	635 $25,000
Q3 2021 Oct 15, 2021	BUY	$46.35 - $59.75 $9,687 - $12,487	209 Added 79.47%	472 $23,000
Q2 2021 Aug 06, 2021	BUY	$47.2 - $67.81 $12,413 - $17,834	263 New	263 $14,000
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $1,373 - $1,824	-92 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$15.01 - $18.89 $1,380 - $1,737	92 New	92 $2,000

Others Institutions Holding VCEL

# of Institutions

277

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Vericel Corp Transaction History